PLIANT THERAPEUTICS, INC. (PLRX) Return on equity 2020–2025
PLIANT THERAPEUTICS, INC. (PLRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-82.4%FY2025 · since FY2020: -14.7% → -82.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -82.4% | -13.3 pp |
| FY2024 | -69.2% | -35.1 pp |
| FY2023 | -34.1% | +5.3 pp |
| FY2022 | -39.4% | +9.5 pp |
| FY2021 | -48.9% | -34.2 pp |
| FY2020 | -14.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More PLRX financial trends
PLRX RevenuePLRX Net incomePLRX Net marginPLRX Gross profitPLRX Gross marginPLRX Operating incomePLRX Operating marginPLRX Operating cash flowPLRX Free cash flowPLRX Capital expendituresPLRX Stock buybacksPLRX Dividends paidPLRX Total assetsPLRX Total liabilitiesPLRX Shareholders’ equityPLRX overview →